534. Preparation for a First-in-Man Lentivirus Trial in Cystic Fibrosis Patients (2016)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1525-0016(16)33343-3
Publication URI: http://www.sciencedirect.com/science?_ob=PublicationURL&_method=list&_hubEid=1-s2.0-S1525001616X61163&_auth=y&_version=1&refS
Type: Journal Article/Review
Parent Publication: Molecular Therapy